Long-Term Liabilities: The sum of all non-current liabilities.
Evommune Inc. (EVMN) had Long-Term Liabilities of $7.30M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-21.67M |
|
-- |
|
-- |
|
$23.95M |
|
$-23.95M |
|
$2.28M |
|
$-21.67M |
|
$-21.67M |
|
$-21.67M |
|
$-21.67M |
|
$-21.67M |
|
$-21.67M |
|
$-23.95M |
|
$-24.40M |
|
33.67M |
|
33.67M |
|
$-0.64 |
|
$-0.64 |
|
| Balance Sheet Financials | |
$215.85M |
|
$1.64M |
|
$106.60M |
|
$322.45M |
|
$10.60M |
|
$0.53M |
|
|
Long-Term Liabilities |
$7.30M |
$17.90M |
|
$304.56M |
|
$304.56M |
|
$304.56M |
|
36.02M |
|
| Cash Flow Statement Financials | |
$-27.50M |
|
$-85.36M |
|
$117.11M |
|
$45.48M |
|
$49.73M |
|
$4.25M |
|
$3.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
20.36 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-27.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.12% |
|
-7.12% |
|
-6.72% |
|
-7.10% |
|
$8.46 |
|
$-0.82 |
|
$-0.82 |
|